MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$0.43
-0.03 (-5.75%)
As of Apr 1, 3:56 PM ET ·
Financial Highlights (FY 2025)
Revenue
5.30M
Net Income
-11,481
Gross Margin
37.4%
Profit Margin
-0.2%
Rev Growth
+3.9%
D/E Ratio
0.42
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 37.4% 37.4% 37.4%
Operating Margin -0.2% -0.2% -0.2%
Profit Margin -0.2% -0.2% -0.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.30M 4.98M 4.38M
Gross Profit 1.98M 1.86M 1.64M
Operating Income -8,164 -8,976 -6,999
Net Income -11,481 -9,902 -8,948
Gross Margin 37.4% 37.4% 37.4%
Operating Margin -0.2% -0.2% -0.2%
Profit Margin -0.2% -0.2% -0.2%
Rev Growth +3.9% +11.7% +7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.67M 8.33M 6.88M
Total Equity 18.34M 20.50M 18.38M
D/E Ratio 0.42 0.41 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -10,930 -11,209 -8,630
Free Cash Flow -9,428 -11,072 -6,340